Recent News

• 11.20.2025 - Publication of revenue and cash position at September 30, 2025
• 11.20.2025 - Publication of revenue and cash position at September 30, 2025
• 11.10.2025 - GENFIT signe un partenariat de recherche avec EVerZom pour faire progresser une technologie de médecine régénérative basée sur les exosomes dans l’ACLF
• 11.10.2025 - GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF
• 10.30.2025 - GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market
• 10.30.2025 - GENFIT annonce son intention de procéder au retrait volontaire de la cotation de ses « American Depositary Shares » sur le Nasdaq Global Select Market
• 10.28.2025 - GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
• 10.28.2025 - GENFIT annonce des avancées dans ses programmes ACLF lors du congrès AASLD The Liver Meeting® 2025
• 09.22.2025 - GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
• 09.22.2025 - GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

Recent Filings

• 10.30.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.30.2025 - EX-99.1 EX-99.1
• 10.28.2025 - EX-99.1 EX-99.1
• 10.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.22.2025 - EX-99.1 EX-99.1